Custom service
Peptide Prenylation
Attach farnesyl or geranylgeranyl chains to peptides for membrane-association studies
Teams come to this service when they need to attach farnesyl or geranylgeranyl chains to peptides for membrane-association studies. We typically start from Cys-terminal prenyl incorporation, add thioether prenyl linkage chemistry where the application demands it, and close the loop with photoreactive prenyl analogs so the final prenylated peptide with lipid confirmation behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 4–6 weeks timeline holds in practice.
Ras and Rho-family C-terminal peptide studies
Membrane-binding motif research
Enzymatic FTase/GGTase labeling on full proteins
Modifications requiring radiological or BSL-3 containment
Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.
Service Highlights
- Cys-terminal prenyl incorporation as the default route, with thioether prenyl linkage chemistry held as a proven fallback
- Photoreactive prenyl analogs worked into the design where the application requires it
- Modification sites are mapped on the sequence and confirmed by MS/MS before release
- Analytical confirmation of every intermediate before the final release
- Modified and unmodified species are separated and quantified, not just reported
- Prenylated peptide with lipid confirmation delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence & modification map
We annotate every modification site, protection strategy and analytical target before synthesis starts.
Solid-phase assembly
The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.
Modification chemistry
Post-synthesis steps — Cys-terminal prenyl incorporation, thioether prenyl linkage chemistry — are run under conditions validated on a test cleavage.
Cleavage & purification
Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.
Analytical release
Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.
Documentation
Prenylated peptide with lipid confirmation is released with the batch record and analytical package after QC sign-off.
Specifications & timeline
- Turnaround
- 4–6 weeks
- Typical scale
- 0.5 mg – 1 g modified peptide
- Chemistry options
- Cys-terminal prenyl incorporation; thioether prenyl linkage chemistry; photoreactive prenyl analogs
- Deliverable
- Prenylated peptide with lipid confirmation
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
- Shipping
- Ambient or blue ice as stability data dictate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.